Congressman Pushes to Unshackle Pharma on Social Media

Sunday, July 5, 2015

Source: FierceBiotechIT

A congressman is taking aim at perceived flaws in FDA's long-awaited, much-discussed guidance on the use of Twitter ($TWTR). The centerpiece of the bill put forward by Rep. Billy Long (R-MO) would allow pharma companies to communicate risks and benefits in hyperlinks, overturning a stipulation of the FDA guidance that severely restricted how the industry can use Twitter.

View All News »